ExodusPoint Capital Management, LP
Position in ELAN — Elanco Animal Health Inc
CIK 1736225
NEW YORK, NY
Position in ELAN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$13,640,865
-$3,633,315 QoQ
Shares Held
570,032
-25.3% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Derivatives in ELAN
reported options exposure · as of Sep 30, 2020CallValue
$0
CallShares
0
PutValue
$1,396,500
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ExodusPoint Capital Management, LP holds $58,166,201 across 15 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
216,322 | $16,408,023 | |
| 2 | ELAN |
Elanco Animal Health Inc
This page
|
570,032 | $13,640,865 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
202,116 | $10,447,376 | |
| 4 | ALKS |
Alkermes plc.
|
204,324 | $7,224,896 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
52,303 | $2,518,389 | |
| 6 | PRGO |
PERRIGO Co plc
|
190,050 | $2,041,137 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
161,700 | $2,009,931 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
190,058 | $1,809,352 |
All Filings in ELAN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,640,865 | 570,032 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $17,274,180 | 763,331 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,472,319 | 271,714 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $2,316,437 | 191,283 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $15,194,425 | 1,034,338 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $494,516 | 34,270 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $2,460,064 | 165,105 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,375,967 | 211,385 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $305,562 | 30,374 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,010,003 | 745,745 | Shares | Other | 2023-05-11 | |
| 2022-09-30 | $2,094,398 | 168,767 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $7,805,987 | 397,656 | Shares | Other | 2022-08-22 | |
| 2021-12-31 | $5,576,386 | 196,490 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $3,307,535 | 103,717 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $2,562,446 | 73,867 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $1,774,244 | 60,246 | Shares | Other | 2021-05-17 | |
| 2020-09-30 | $1,396,500 | 50,000 | Put | Sole | 2020-11-16 | |
| 2020-09-30 | $876,387 | 31,378 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,260,401 | 105,380 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||